Vir Biotechnology, Inc.
VIR
$9.40
$0.111.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -29.00K | 60.68M | 240.00K | 1.21M | 1.17M |
| Total Other Revenue | -- | 3.39M | -- | -- | 1.86M |
| Total Revenue | -29.00K | 64.07M | 240.00K | 1.21M | 3.03M |
| Cost of Revenue | 109.81M | 88.46M | 151.45M | 97.52M | 117.62M |
| Gross Profit | -109.84M | -24.39M | -151.21M | -96.31M | -114.58M |
| SG&A Expenses | 23.34M | 23.62M | 22.23M | 22.28M | 23.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.15M | 112.07M | 173.68M | 119.80M | 141.56M |
| Operating Income | -133.18M | -48.00M | -173.44M | -118.59M | -138.53M |
| Income Before Tax | -125.53M | -43.06M | -162.97M | -110.79M | -120.95M |
| Income Tax Expenses | 170.00K | -137.00K | 168.00K | 170.00K | 16.00K |
| Earnings from Continuing Operations | -125.70M | -42.92M | -163.14M | -110.96M | -120.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -125.70M | -42.92M | -163.14M | -110.96M | -120.97M |
| EBIT | -133.18M | -48.00M | -173.44M | -118.59M | -138.53M |
| EBITDA | -130.37M | -45.10M | -170.45M | -115.67M | -135.66M |
| EPS Basic | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 |
| Normalized Basic EPS | -0.54 | -0.18 | -0.74 | -0.49 | -0.57 |
| EPS Diluted | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 |
| Normalized Diluted EPS | -0.54 | -0.18 | -0.74 | -0.49 | -0.57 |
| Average Basic Shares Outstanding | 147.36M | 139.23M | 138.93M | 138.45M | 137.47M |
| Average Diluted Shares Outstanding | 147.36M | 139.23M | 138.93M | 138.45M | 137.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |